Metabolism of resveratrol in breast cancer cell lines: Impact of sulfotransferase 1A1 expression on cell growth inhibition

Cancer Letters

Volumn 261, Issue 2, 2008, Pages 172-182

  Murias, Marek ^a,c   Miksits, Michaela ^a   Aust, Sylvia ^b   Spatzenegger, Margit ^a   Thalhammer, Theresia ^b   Szekeres, Thomas ^b   Jaeger, Walter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Human breast cancer cells; PCR; Resveratrol; Sulfation; SULTs

Indexed keywords

DRUG METABOLITE; MESSENGER RNA; RESVERATROL; RESVERATROL 3 O SULFATE; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG METABOLISM; GRAPE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARYLSULFOTRANSFERASE; BREAST NEOPLASMS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH INHIBITORS; HUMANS; MASS SPECTROMETRY; NEOPLASMS, HORMONE-DEPENDENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; TUMOR CELLS, CULTURED;

VITACEAE;

EID: 39149104669     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.008     Document Type: Article

References (37)

1. Limer J.L., and Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 6 (2004) 119-127
2. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840
3. Banerjee S., Bueso-Ramos C., and Aggarwal B.B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62 (2002) 4945-4954
4. Levi F., Pasche C., Lucchini F., Ghidoni R., Ferraroni M., and La V.C. Resveratrol and breast cancer risk. Eur. J. Cancer Prev. 14 (2005) 139-142
5. Bove K., Lincoln D.W., and Tsan M.F. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 291 (2002) 1001-1005
6. Garvin S., Ollinger K., and Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 231 (2006) 113-122
7. Nakagawa H., Kiyozuka Y., Uemura Y., Senzaki H., Shikata N., Hioki K., and Tsubura A. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J. Cancer Res. Clin. Oncol. 127 (2001) 258-264
8. Pozo-Guisado E., Alvarez-Barrientos A., Mulero-Navarro S., Santiago-Josefat B., and Fernandez-Salguero P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 64 (2002) 1375-1386
9. Fontecave M., Lepoivre M., Elleingand E., Gerez C., and Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421 (1998) 277-279
10. Ragione F.D., Cucciolla V., Boriello A., Pietra V.D., Racioppi L., Soldati G., Manna C., Galletti P., and Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250 (1998) 53-58
11. Murias M., Jäger W., Handler N., Erker T., Horvath Z., Szekers T., Nohl H., and Gille L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 69 (2005) 903-912
12. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., Szekeres T., and Jäger W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 12 (2004) 5571-5578
13. Marier J.F., Vachon P., Gritsas A., Zhang J., Moreau J.P., and Ducharme M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302 (2002) 369-373
14. Meng X., Maliakal P., Lu H., Lee M.J., and Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 52 (2004) 935-942
15. Yu C., Shin Y.G., Chow A., Li Y., Kosmeder J.W., Lee Y.S., Hirschelman W.H., Pezzuto J.M., Mehta R.G., and van Breemen R.B. Human, rat, and mouse metabolism of resveratrol. Pharm Res 19 (2002) 1907-1914
16. Aumont V., Krisa S., Battaglia E., Netter P., Richard T., Merillon J.M., Magdalou J., and Sabolovic N. Regioselective and stereospecific glucuronidation of trans- and cis- resveratrol in human. Arch Biochem Biophys 393 (2001) 281-289
17. Miksits M., Maier-Salamon A., Aust S., Thalhammer T., Reznicek G., Kunert O., Haslinger E., Szekeres T., and Jaeger W. Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35 (2005) 1101-1119
18. Aust S., Obrist P., Klimpfinger M., Tucek G., Jäger W., and Thalhammer T. Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue. Int. J. Oncol. 26 (2005) 1079-1085
19. Guillemette C., Ritter J.K., Auyeung D.J., Kessler F.K., and Housman D.E. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10 (2000) 629-644
20. Gestl S.A., Green M.D., Shearer D.A., Frauenhoffer E., Tephly T.R., and Weisz J. Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am. J. Pathol. 160 (2002) 1467-1479
21. A. Maier-Salamon, B. Hagenauer, G. Reznicek, T. Szekeres, T. Thalhammer, W. Jäger, Metabolism and disposition of resveratrol in the isolated perfused rat liver: Role of Mrp2 in the biliary excretion of glucuronides, J. Pharm. Sci. 2007; aug 27, [Epub ahead of print].
22. Vichai V., and Kirtikara K. Sulforhodamine B calorimetric assay for cytotoxic screening. Nat. Protoc. 1 (2006) 1112-1116
23. Dooley T.P., Haldeman-Cahill R., Joiner J., and Wilborn T.W. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem. Biophys. Res. Commun. 277 (2000) 236-245
24. Aust S., Jaeger W., Klimpfinger M., Mayer K., Baravalle G., Ekmekcioglu C., and Thalhammer T. Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1. J. Pineal Res. 39 (2005) 276-282
25. Tabrett C.A., and Coughtrie M.W. Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate. Biochem. Pharmacol 66 (2003) 2089-2097
26. Ung D., and Nagar S. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1. Drug Metab. Dispos. 35 (2007) 740-746
27. Hutzler J.M., and Tracy T.S. Atypical kinetic profiles in drug metabolism reactions. Drug Metab. Dispos. 30 (2002) 355-362
28. Kroon P.A., Clifford M.N., Crozier A., Day a.J., Donovan J.L., Manach C., and Williamson G. Am. J. Clin. Nutr. 80 (2004) 15-21
29. Spink B.C., Katz B.H., Hussain M.M., Pang S., Connor S.P., Aldous K.M., Gierthy J.F., and Spink D.C. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis 21 (2000) 1947-1957
30. Peterson T.G., Coward L., Kirk M., Falany C.N., and Barnes S. The role of metabolism in mammary epithelial cell gowth inhibition by the isoflavones genistein and bichanin A. Carcinogenesis 17 (1996) 1861-1869
31. Maier-Salamon A., Hagenauer B., Wirth M., Gabor F., Szekeres T., and Jäger W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm. Res. 23 (2006) 2107-2115
32. Chandra P., and Brouwer K.L. The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res. 21 (2004) 719-735
33. Cooray H.C., Janvilisri T., van Veen H.W., Hladky S.B., and Barrand M.A. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317 (2004) 269-275
34. Damianaki A., Bakogeorgou E., Kampa M., Notas G., Hatzoglou A., Panagiotou S., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell Biochem. 78 (2000) 429-441
35. Falany J.L., and Falany C.N. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res. 56 (1996) 1551-1555
36. Glatt H., Engelke C.E., Pabel U., Teubner W., Jones A.L., Coughtrie M.W., Andrae U., Falany C.N., and Meinl W. Sulfotransferases: genetics and role in toxicology. Toxicol. Lett. 112-113 (2000) 341-348
37. Glatt H., Boeing H., Engelke C.E., Ma L., Kuhlow A., Pabel U., Pomplun D., Teubner W., and Meinl W. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat. Res. 482 (2001) 27-40